Russia approves coronavirus vaccine before final clinical trials are completed

Russia has become the first country to grant regulatory approval to a coronavirus vaccine, after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess. But the vaccine has yet to complete final trials, raising serious concerns among some experts.